📋 Tender Overview
Project Number
51132
Company Name
Isa Home Lab Analises Clinicas e Vacinacoes Ltda.
Date ESRS Disclosed
May 19, 2025
Country
Brazil
Region
Latin America and the Caribbean
Last Updated Date
Environmental Category
B
Status
Pending Approval
Sector
other
Industry
other
Department
Disruptive Tech, Service & Funds
Project Description
ISA Lab ( ISA or the Company ) is a tech enabled healthcare services company in Brazil. It offers homecare medical services such as vaccination, testing, infusion, clinical visits, and chronic disease management at the patient’s home. ISA operates a B2B (business-to-business)/B2B2C (business-to-business-to-consumer) model connecting individual medical professionals ( ISAs ) to patients. It has a decentralized model and a network of independent healthcare professionals currently operating in 65 cities across Brazil. ISA does not operate any healthcare facilities and services are limited to home visits where healthcare professionals go directly to the patient's residence to provide medical care and support.
Overview of IFC's Scope of Review
IFC’s environmental and social (E&S) review of the project consisted of: (i) the review of environmental, labor, health, safety and social information provided by the Company, and (ii) meetings with ISA representatives and management personal, who were interviewed on April 10th and 11th 2025 during the virtual appraisal.
